A Parkinson's disease lab located at University of Ottawa. We focus on many different approaches to understand the pathogenesis of PD.
University of Ottawa
Joined January 2020
- Tweets17
- Following44
- Followers113
- Likes10
Pinned Tweet
Our story is out on @biorxivpreprint! Thank you to all of our coauthors and especially to the all the patients and their families that make human brain research possible. biorxiv.org/content/10.1101/…
Schlossmacher Lab retweeted
Congratulations to the 2019 CAN-CIHR-INMHA Brain Star Award Winners! can-acn.org/congratulations-… @cihr_inmha @RockyMtnBrain
Schlossmacher Lab retweeted
Meta analysis suggests patients with various bacterial, viral, & fungal infections (Helicobacter pylori, hepatitis C virus, Malassezia, & pneumoniae) might have increased risk of #Parkinsons. Antiviral treatment of HCV could reduce the risk of PD
onlinelibrary.wiley.com/doi/…
Schlossmacher Lab retweeted
We are celebrating the timely Me and My Microbes exhibition @museumofnature with special announcement of funding from @CIHR_IRSC for microbiome research across Canada, including @UCalgary. Visit the exhibition until March 29.
On Thursday night, some members of our lab attended the VIP event for the Me & My Microbes exhibit at the @MuseumofNature!
Schlossmacher Lab retweeted
New @ParkinsonsUK research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
👉Find out more at parkinsons.org.uk/news/gut-b…
Our new #PhD student Michaela Lunn gave an oral presentation at the recent OHRI Research Day in November and took home the first place prize! Michaela studies the immune properties of PD-linked protein #LRRK2. @OttawaHospital
Meet our senior #PhD candidate Daniel El Kodsi. Daniel has been producing exciting work in the Schlossmacher lab for many years. Stay tuned for exciting #firstauthor papers from Daniel coming soon!
This Post is from an account that no longer exists. Learn more
A word cloud from the final thesis of our Master's student, Christopher Rousso, who successfully defended his thesis in November. Chris has done exciting work on the role of alpha-synuclein in the #immunesystem both in the brain and the periphery.
Schlossmacher Lab retweeted
Dr. Michael Schlossmacher's research aims to unravel some of the mystery around #Parkinson’s, a disease for which there is no cure, or even a way to slow the progress.
His team's latest study is a step in that direction.
ottawacitizen.com/news/local… #onHWS @uOttawaBMRI @uottawa
Take a look at our paper from 2017 to see our findings on possible anti-microbial effects of #alphasynuclein and an exciting new staining technique created by our lab
David Beckham's lab has shown that alpha synuclein has antiviral properties ( ncbi.nlm.nih.gov/pmc/article… ), & Michael Schlossmacher's lab has a similar line of research (ncbi.nlm.nih.gov/pmc/article…). So this new PARKIN research is interesting from this standpoint as well
Schlossmacher Lab retweeted
Dr. Michael Schlossmacher speaking about Parkinson's research #letstalkparkinsons #tenderlovingresearch #TLR
Please see our most recently published paper in #STM for exciting research connecting PD-linked protein LRRK2 with an important role in immune defences. We also identified an interesting #sexdifference.
A gene that has been linked to #Parkinsons disease controls the course of certain bacterial and viral infections in mice in a sex-specific manner. Read the new research from @uOttawa. #InfectiousDisease fcld.ly/e5q1x74
